Crop raiding and conflict: Farmers’ perceptions of human-wildlife interactions in Hoima district, Uganda

Conflict between humans and crop raiding wildlife is a growing problem, particularly in tropical, unmechanised farming communities where increased competition for resources intensifies the likelihood of human-wildlife interactions. However, conflict can arise as much from perceptions of risk as actual damage, and perceived and actual degrees of risk do not always match. Hoima District in Uganda reportedly has a long-standing issue of crop raiding. Forest fragments in northern Hoima District support chimpanzees and other primates, and are surrounded by a mosaic of farms. During this study crop damage was monitored in farms next to four forest fragments each week for one year (November 2006 to November 2007), and farmers’ attitudes to crop raiding were explored through interviews and focus groups. Most farms lost less than 1% of their crops, and more than half of farms did not experience crop damage by large vertebrates (primates, porcupine, bush pig and civet). Cattle were responsible for over one third of the total area of damage; more than all other large vertebrates combined. Whilst local people do not consider crop raiding by wildlife to be as severe a risk to crops as disease and weather, conflict with wild animals does exist. Farmers’ attitudes appear less influenced by the area of crop damaged than by the frequency of damage events (real or perceived) and by factors external to crop loss: i) ability to control loss and impacts of loss, ii) a fear of personal safety, iii) labour requirements of managing crops. That farmers’ opinions of crop raiding animals appear to be shaped more by these external factors than by actual levels of crop loss is a likely consequence of the low level of damage present in the study sites. This research illustrates that perceptions of conflict between humans and crop raiding animals should always be examined in tandem with actual losses, and that conflict may persist in areas where little loss occurs. Employment of amelioration techniques must therefore be selected with care, as inappropriate use of these tools risks focusing farmers’ frustrations onto crop raiding activities and exacerbating conditions

Worry and Hope: What College Students Know, Think, Feel, and Do about Climate Change

“Colleges and universities can only thrive if society and the biosphere are healthy. Any institution that is so shortsighted as to pursue its ends without taking into account the interests of the larger community or ecosystem in which it is enmeshed will not achieve sustainable success. In the end, it will find itself forced, one way or another, to deal with the fact that its future is linked to that of the larger web of social and ecological relations” (Bardaglio & Putman, 2009, p. 174). “You are not mature enough to tell it like it is. Even that burden you leave to us children” (Thunberg, 2018)

BRIDGE RAILS AND TRANSITIONS FOR PEDESTRIAN PROTECTION

It is desirable to protect pedestrians on bridges from motor vehicles. However, transition problems arise at the ends of bridges where the bridge rail, bridge rail end treatment, and pedestrian walkway compete for the limited available space. The objective of this study was to identify the most common scenarios in which the protection of pedestrians on bridges is desirable, and then to develop bridge rail and bridge rail end treatment configurations to accommodate those situations. The objective was achieved by performing a field investigation, a survey of state transportation agencies, and a literature review. Recommendations for the placement and general design of standard barrier configurations have been provided in the form of thirteen generalized site drawings. The barrier configurations outlined within this report were based on NCHRP Report No. 350 approved hardware, roadside hardware meeting prior safety standards, hardware believed to provide moderate safety, hardware currently under development, and sound engineering judgement. Therefore, the barrier configurations recommended herein are not equivalent in terms of the level of pedestrian safety provided. As a result, sound engineering judgement is required when determining which barrier configuration to implement for providing pedestrian protection on and near the ends of bridges

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer

The aim of this study was to investigate the anticancer activity and mechanism of action of Noscapine alone and in combination with Doxorubicin against triple negative breast cancer (TNBC).TNBC cells were pretreated with Noscapine or Doxorubicin or combination and combination index values were calculated using isobolographic method. Apoptosis was assessed by TUNEL staining. Female athymic Nu/nu mice were xenografted with MDA-MB-231 cells and the efficacy of Noscapine, Doxorubicin and combination was determined. Protein expression, immunohistochemical staining were evaluated in harvested tumor tissues. values of 36.16±3.76 and 42.7±4.3 µM respectively. The CI values (<0.59) were suggestive of strong synergistic interaction between Noscapine and Doxorubicin and combination treatment showed significant increase in apoptotic cells. Noscapine showed dose dependent reduction in the tumor volumes at a dose of 150–550 mg/kg/day compared to controls. Noscapine (300 mg/kg), Doxorubicin (1.5 mg/kg) and combination treatment reduced tumor volume by 39.4±5.8, 34.2±5.7 and 82.9±4.5 percent respectively and showed decreased expression of NF-KB pathway proteins, VEGF, cell survival, and increased expression of apoptotic and growth inhibitory proteins compared to single-agent treatment and control groups.Noscapine potentiated the anticancer activity of Doxorubicin in a synergistic manner against TNBC tumors via inactivation of NF-KB and anti-angiogenic pathways while stimulating apoptosis. These findings suggest potential benefit for use of oral Noscapine and Doxorubicin combination therapy for treatment of more aggressive TNBC

Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

BACKGROUND AND PURPOSE: Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and atrial fibrillation/flutter (AF/AFL) from CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) and a meta-Analysis of large cardiovascular outcome trials (CVOTs) of SGLT2i in type 2 diabetes mellitus. METHODS: CREDENCE randomized 4401 participants with type 2 diabetes mellitus and chronic kidney disease to canagliflozin or placebo. Post hoc, we estimated effects on fatal or nonfatal stroke, stroke subtypes, and intermediate markers of stroke risk including AF/AFL. Stroke and AF/AFL data from 3 other completed large CVOTs and CREDENCE were pooled using random-effects meta-Analysis. RESULTS: In CREDENCE, 142 participants experienced a stroke during follow-up (10.9/1000 patient-years with canagliflozin, 14.2/1000 patient-years with placebo; hazard ratio [HR], 0.77 [95% CI, 0.55-1.08]). Effects by stroke subtypes were: ischemic (HR, 0.88 [95% CI, 0.61-1.28]; n=111), hemorrhagic (HR, 0.50 [95% CI, 0.19-1.32]; n=18), and undetermined (HR, 0.54 [95% CI, 0.20-1.46]; n=17). There was no clear effect on AF/AFL (HR, 0.76 [95% CI, 0.53-1.10]; n=115). The overall effects in the 4 CVOTs combined were: Total stroke (HRpooled, 0.96 [95% CI, 0.82-1.12]), ischemic stroke (HRpooled, 1.01 [95% CI, 0.89-1.14]), hemorrhagic stroke (HRpooled, 0.50 [95% CI, 0.30-0.83]), undetermined stroke (HRpooled, 0.86 [95% CI, 0.49-1.51]), and AF/AFL (HRpooled, 0.81 [95% CI, 0.71-0.93]). There was evidence that SGLT2i effects on total stroke varied by baseline estimated glomerular filtration rate (P=0.01), with protection in the lowest estimated glomerular filtration rate (45 mL/min/1.73 m2]) subgroup (HRpooled, 0.50 [95% CI, 0.31-0.79]). CONCLUSIONS: Although we found no clear effect of SGLT2i on total stroke in CREDENCE or across trials combined, there was some evidence of benefit in preventing hemorrhagic stroke and AF/AFL, as well as total stroke for those with lowest estimated glomerular filtration rate. Future research should focus on confirming these data and exploring potential mechanisms

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to 300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m 2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Design of a reliable computing system for the Petite Amateur Navy Satellite (PANSAT).

This thesis proposes a processor design for the Petite Amateur Navy Satellite (PANSAT). The missions of PANSAT are considered. It compares the design of three previous satellites with similar missions and determines the processor functions required to support PANSAT missions. Particular attention is given to the store and forward message system. A reliable processor design that implements these functions is developed. The reliability of the proposed design is examined. Minimum software requirements for the resulting design are listed.http://archive.org/details/designofreliable00hiseLieutenant, United States NavyApproved for public release; distribution is unlimited

BRIDGE RAILS AND TRANSITIONS FOR PEDESTRIAN PROTECTION

It is desirable to protect pedestrians on bridges from motor vehicles. However, transition problems arise at the ends of bridges where the bridge rail, bridge rail end treatment, and pedestrian walkway compete for the limited available space. The objective of this study was to identify the most common scenarios in which the protection of pedestrians on bridges is desirable, and then to develop bridge rail and bridge rail end treatment configurations to accommodate those situations. The objective was achieved by performing a field investigation, a survey of state transportation agencies, and a literature review. Recommendations for the placement and general design of standard barrier configurations have been provided in the form of thirteen generalized site drawings. The barrier configurations outlined within this report were based on NCHRP Report No. 350 approved hardware, roadside hardware meeting prior safety standards, hardware believed to provide moderate safety, hardware currently under development, and sound engineering judgement. Therefore, the barrier configurations recommended herein are not equivalent in terms of the level of pedestrian safety provided. As a result, sound engineering judgement is required when determining which barrier configuration to implement for providing pedestrian protection on and near the ends of bridges

Determination of potential solar power sites in the United States based upon satellite cloud observations

The use of cloud images in the visual spectrum from the SMS/GOES geostationary satellites to determine the hourly distribution of sunshine on a mesoscale in the continental United States excluding Alaska is presented. Cloud coverage and density as a function of time of day and season are evaluated through the use of digital data processing techniques. Low density cirrus clouds are less detrimental to solar energy collection than other types; and clouds in the morning and evening are less detrimental than those during midday hours of maximum insolation. Seasonal geographic distributions of cloud cover/sunshine are converted to langleys of solar radiation received at the earth's surface through relationships developed from long term measurements at six widely distributed stations